| Officer | Age | In this role | Joined | 2025 pay | Source |
|---|---|---|---|---|---|
|
Joseph K. Belanoff
Also a director
Chief Executive Officer, President and Director
|
68 | Not stated | Not stated | $15,303,551 | |
|
Atabak Mokari
Chief Financial Officer and Treasurer
|
49 | Not stated | Not stated | $6,135,667 | |
|
William Guyer
Chief Development Officer
|
58 |
Since 2021
5 years
|
Not stated | $6,340,445 | |
|
Hazel Hunt
Chief Scientific Officer
|
66 |
Since 2020
6 years
|
2011 | Not reported | |
|
Charles Robb
Chief Business Officer and Secretary
|
63 | Not stated | Not stated | $6,380,500 | |
|
Roberto Wandenkolk Vieira
President, Oncology
Title from the Form 4 dated Oct 2, 2026
|
Not stated | Not stated | Not stated | Not reported | |
|
Joseph D. Lyon
See Remarks
Title from the Form 4 dated Oct 1, 2026
|
48 | Not stated | 2012 | Not reported | |
|
Sean Maduck
See Remarks
Title from the Form 4 dated Oct 1, 2026
|
49 | Not stated | 2012 | $6,208,642 | |
|
Justin Frederick Gunn
See Remarks
Title from the Form 4 dated Oct 1, 2026
|
Not stated | Not stated | Not stated | Not reported |
Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.
Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.
The proxy filed Apr 17, 2026 states there were none.
Read it in the proxyLoading...
